EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte Studie

Clinical effort against smoke exposure in cystic fibrosis (CEASE-CF): feasibility, acceptability, and preliminary efficacy

Gabriela R Oates, Robin Geurs, Cathy Mims, Stephanie Gamble, Lucia D Juarez, B Grey Vandeberg, Sigrid Ladores-Barrett, William T Harris

Journal of Cystic Fibrosis · 2026

DOI: 10.1016/j.jcf.2026.01.007 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Journal of Cystic Fibrosis, 2026. Verfasst von Gabriela R Oates und 7 weiteren Autor:innen. Beteiligte Einrichtung: Pulmonary, Allergy, and Critical Care Medicine, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA. Electronic add…. Hauptthemen laut MEDLINE: Smoking Cessation, Cystic Fibrosis, Tobacco Smoke Pollution, Caregivers. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 37 Literaturangaben. Gefördert von: National Institute of Diabetes and Digestive and Kidney Diseases, Cystic Fibrosis Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Smoke exposure affects one-third of children with CF (CwCF), but smoking cessation strategies for their caregivers have not been tested. METHODS: We developed and tested CEASE-CF, a randomized controlled smoking cessation intervention tailored to smoking caregivers of CwCF and delivered by a tobacco treatment specialist (TTS) integrated into the CF care team. The intervention arm received CF-specific smoke exposure education, intake assessment, and treatment (nicotine replacement therapy and 12 counseling sessions over 6 months). The control arm received education. Primary outcomes were feasibility and acceptability among caregivers and providers. Secondary outcomes were 6-month quit rates and child hair nicotine concentrations. RESULTS: 36 caregivers (24 intervention, 12 control) were recruited. Feasibility (64% accrual, 100% retention) and acceptability (86% caregivers satisfied and likely to recommend CEASE-CF, 67% finding it helpful) were high. Providers' (n = 19) mean scores were 4.7 (1-5 scale) for satisfaction, implementation, and recommendation to other clinics. At 6 months, 17% participants had quit smoking, and 78% had a 7-day point prevalence reduction of at least 17%, with an average reduction of 54%. Hair nicotine decreased from 2.7 (SE 0.17) ng/mg at baseline to 1.1 (SE 0.17) ng/mg at 6 months (p < 0.001). At baseline, all hair nicotine specimens were above the exposure threshold of 1.0 ng/mg, but only 41% at 6 months. CONCLUSIONS: Tobacco treatment delivered by a TTS part of the CF care team reduces smoke exposure in CwCF. CEASE-CF is a feasible and acceptable model for smoking cessation that can be incorporated into CF clinical care.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Smoking CessationCystic FibrosisTobacco Smoke PollutionCaregiversHumansFemaleMaleNicotine Replacement TherapyFeasibility StudiesChildCounselingPatient Acceptance of Health CareAdultHair

Stichwörter der Autor:innen

Cystic fibrosisFeasibilitySmoking cessationTobacco

Substanzen

Tobacco Smoke Pollution

Autor:innen und Institutionen

  • Pulmonary, Allergy, and Critical Care Medicine, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA. Electronic address: goates@uabmc.edu.
  • Pulmonary, Allergy, and Critical Care Medicine, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA.
  • Children's of Alabama, Birmingham, AL, USA.
  • General Internal Medicine and Population Science, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA.
  • School of Nursing, University of Nevada Las Vegas, Las Vegas, NV, USA.
  • Pediatric Pulmonary and Sleep Medicine, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA.

Förderung

  • National Institute of Diabetes and Digestive and Kidney Diseases
  • Cystic Fibrosis Foundation

Zitieren

APA

Oates, G. R., Geurs, R., Mims, C., Gamble, S., Juarez, L. D., Vandeberg, B. G., Ladores-Barrett, S., & Harris, W. T. (2026). Clinical effort against smoke exposure in cystic fibrosis (CEASE-CF): feasibility, acceptability, and preliminary efficacy. Journal of Cystic Fibrosis. https://doi.org/10.1016/j.jcf.2026.01.007

Vancouver

Oates GR, Geurs R, Mims C, Gamble S, Juarez LD, Vandeberg BG, et al. Clinical effort against smoke exposure in cystic fibrosis (CEASE-CF): feasibility, acceptability, and preliminary efficacy. Journal of Cystic Fibrosis. 2026. doi:10.1016/j.jcf.2026.01.007

BibTeX
@article{Oates2026,
  author = {Oates, Gabriela R and Geurs, Robin and Mims, Cathy and Gamble, Stephanie and Juarez, Lucia D and Vandeberg, B Grey and Ladores-Barrett, Sigrid and Harris, William T},
  title = {Clinical effort against smoke exposure in cystic fibrosis (CEASE-CF): feasibility, acceptability, and preliminary efficacy},
  journal = {Journal of Cystic Fibrosis},
  year = {2026},
  doi = {10.1016/j.jcf.2026.01.007}
}
Kostenlos starten →